Skip to main content
SpringerLink
Log in

Treatment of hypertension

Patterns of drug utilization in a metropolitan population

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

In the Munich Blood Pressure Study (MBS), a cross-sectional study (MBS I) with follow-up (MBS II) of a random sample of 3,198 citizens aged 30–69 (response rate, 69.3%), treatment and control of hypertension were examined.

Of the actual hypertensives 59% (221) in MBS II (373) were on drug treatment and about two-thirds (150) of those being treated had controlled blood pressure (BP). Women's BP was better controlled than men's.

Of the 221 treated hypertensives 85% (188) received types of drugs or drug combinations which were in accordance with the recommendations of the German Hypertension League. However, this did not apply to the prescribed dosages of the various drugs. Of the treated hypertensives 52% were either on a diuretic, on a beta-blocker, or on a combination of both drugs. Rauwolfia alkaloids combined with a diuretic were given to 27%.

In 79% of the participants who had received a beta-blocker either alone or in combination with other antihypertensive agents and who still had high BP values, the prescribed beta-blocker dosage was below the recommended daily dose. Fatigue was the most frequently reported symptom, possibly attributable to antihypertensive drug treatment.

Electrocardiographic signs of left ventricular hypertrophy were found less frequently in controlled hypertensives, in comparison to treated but uncontrolled hypertensives or untreated hypertensives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AV:

Atrioventricular

BMI:

Body mass index

BP:

Blood pressure

DBP:

Diastolic blood pressure

GKV:

Gesetzliche Krankenversicherung

ISH:

International society for hypertension

LVH:

Left ventricular hypertrophy

MBS:

Munich blood pressure study

NHANES:

National health and nutrition examination survey

SBP:

Systolic blood pressure

References

  1. Bray GA (1978) Definition, measurement and classification of the syndromes of obesity. Int J Obesity 2:99–112

    Google Scholar 

  2. Breithaupt H (1983) Behandlung der Hypertonie. Schattauer, Stuttgart New York

    Google Scholar 

  3. Capella D, Porta M, Laporte JR (1983) Utilization of anti-hypertensive drugs in certain European countries. Eur J Clin Pharmacol 25:431–435

    Google Scholar 

  4. Connolly DC, Elveback LR, Oxman HA (1983) Coronary heart disease in residents of Rochester, Minnesota, 1950–1975. III. Effects of hypertension and its treatment on survival of patients with coronary artery disease. Mayo Clin Proc 58:249–254

    Google Scholar 

  5. Der pharmazeutische Markt Deutschlands — DPM 1981. Institut für medizinische Statistik — IMS GmbH, Frankfurt/Main

  6. Deutsche Liga zur Bekämpfung des hohen Blutdruckes eV (1980) Empfehlungen zur Hochdruckbehandlung in der Praxis und zur Behandlung hypertensiver Notfälle, 3rd edn

  7. Drayer JIM, Weber MA, Gardin JM, Lipson JL (1983) Effect of long-term antihypertensive therapy on cardiac anatomy in patients with essential hypertension. Am J Cardiol 75:116–120

    Google Scholar 

  8. Dreslinski GR (1983) Identification of left ventricular hypertrophy: chest roentgenography, echocardiography, and electrocardiography. Am J Cardiol 75:47–50

    Google Scholar 

  9. Folsom AR, Luepker RV, Gillum RF, Jacobs DR, Prineas RJ, Taylor HL, Blackburn H (1983) Improvement in hypertension detection and control from 1973–1974 to 1980–1981. The Minnesota Heart Survey Experience. JAMA 25:916–921

    Google Scholar 

  10. Frishman W, Silverman R (1979) Clinical pharmacology of the new betaadrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications. Am Heart J 98:119–131

    Google Scholar 

  11. GKV-Arzneimittelindex 1982 (1983) Wissenschaftliches Institut der Ortskrankenkassen (WIdO), Bonn

  12. Gross F (1981) Drug utilization — theory und practice. The present situation in the Federal Republic of Germany. Eur J Clin Pharmacol 19:387–394

    Google Scholar 

  13. Guidelines for the treatment of mild hypertension (1983) Memorandum from a WHO/ISH meeting. Bull WHO 61(1):53–56

    Google Scholar 

  14. Hypertension detection and follow-up program cooperative group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242:2562–2571

    Google Scholar 

  15. Hypertension detection and follow-up program cooperative group (1979) Five-year findings of the hypertension detection and follow-up program. II. Mortality by race, sex and age. JAMA 242:2572–2577

    Google Scholar 

  16. Hypertension detection and follow-up program cooperative group (1982) Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 247:633–638

    Google Scholar 

  17. Hypertension detection and follow-up program cooperative group (1982) The effect of treatment on mortality in “mild” hypertension. N Engl J Med 307:976–980

    Google Scholar 

  18. Kannel WB (1983) Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Cardiol 75:4–11

    Google Scholar 

  19. Keil U, Döring A, Stieber J (1983) Community studies in the Federal Republic of Germany. In: Gross F, Strasser T (eds) mild hypertension: recent advances. Raven Press, New York, pp 63–83

    Google Scholar 

  20. Kirkendall WM, Feinleib M, Freis E, Mark AL (1981) Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA postgraduate education committee. Hypertension 3:510A-519A

    Google Scholar 

  21. Lenfant C, Roccella EJ (1984) Trends in hypertension control in the United States. Chest 86:459–462

    Google Scholar 

  22. Management committee (1980) The Australien therapeutic trial in mild hypertension. Lancet I:1261–1267

    Google Scholar 

  23. Materson BJ, Oster JR, Michael UF (1978) Dose response to chlorthalidone in patients with mild hypertension. Clin Pharmacol Ther 24:192–196

    Google Scholar 

  24. Pöppl SJ, Herrmann G, Luft R (1982) Experiences in developing of a stand-alone ECG acquisition and analysis system. Proceedings MEDCOMP 82, 1st IEEE Computer Society International Conference on Medical Computer Science/Computational Medicine, Philadelphia/USA

  25. Romhilt DW, Estes EH (1968) A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 6:752–758

    Google Scholar 

  26. Stieber J, Döring A, Keil U (1982) Häufigkeit, Bekanntheits- und Behandlungsgrad der Hypertonie in einer Großstadtbevölkerung. Münch Med Wochenschr 124:747–752

    Google Scholar 

  27. Tarazi RC (1983) Regression of left ventricular hypertrophy by medical treatment: present status and possible implications. Am J Cardiol 75:80–86

    Google Scholar 

  28. Tweeddale MG, Ogilvie RI, Ruedy J (1977) Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther 22:519–524

    Google Scholar 

  29. Verschreibungsindex für Pharmazeutika (1980) — VIP, IV. Quartal 1980. Institut für medizinische Statistik, Frankfurt/Main

  30. Veterans administration cooperative study group on antihypertensive agents (1967) Effects of treatment on mortality in hypertension. I. Results in patients with diastolic blood pressure average 115 through 129 mm Hg. JAMA 202:1028–1034

    Google Scholar 

  31. Veterans administration cooperative study group on antihypertensive agents (1970) Effects of treatment on morbidity in hypertension: II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 231:1143–1152

    Google Scholar 

  32. Waal-Manning HJ (1976) Hypertension: which beta-blocker? Drugs 12:412–441

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GSF/MEDIS-Institut, München-Neuherberg

    W. Koenig, U. Keil, S. Perz, J. Stieber & A. Döring

  2. Medizinische Universitätsklinik, Steinhövelstr. 9, D-7900, Ulm/Donau

    W. Koenig

Authors
  1. W. Koenig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Keil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Perz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Stieber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Döring
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koenig, W., Keil, U., Perz, S. et al. Treatment of hypertension. Klin Wochenschr 64, 1229–1236 (1986). https://doi.org/10.1007/BF01734464

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01734464

Key words

Search

Navigation